4
Changes in Ownership
Neurogene Inc. Filed Acc 0001209191-15-026541
Options or other derivatives
- President and CEO acquired 65,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Main David · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-03-12 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +65,000 | $12.03 | 2025-03-11 | 65,000 | 65,000 | D |
Loading xslF345X03/doc4.xml…